Raymond W. Cohen is a veteran MedTech executive and public company director with more than 40 years of leadership experience. He co-founded and led Axonics through its $3.7 billion acquisition by Boston Scientific in 2024 and serves as Chairman of SoniVie, which was acquired by Boston Scientific for $600 million in 2025. Cohen currently serves on multiple medical technology company boards and is a venture partner with Andera Partners and Sherpa Capital. He holds a B.S. in Business Management from Binghamton University.